Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

142 results
Display

Physiological spaces and multicompartmental pharmacokinetic models

Atkinson A

The idea of body compartments has its origins in physiology and antedates their use in both physiologically-based predictive pharmacokinetic models and in the simpler compartmental models used to analyze pharmacokinetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Derivation of pharmacokinetic equations

Noh GJ

A variety of drugs are continuously or intermittently administered to patients during general or regional anesthesia. Pharmacotherapy should also receive priority compared with several treatment modalities including nerve blocks for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Contributing Factors on Pharmacokinetic Variability in Critically Ill Neonates

An SH

Neonates have large inter-individual variability in pharmacokinetic parameters of many drugs due to developmental differences. The aim of this study was to investigate the factors affecting the pharmacokinetic parameters of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How to design intravenous anesthetic dose regimens based on pharmacokinetics and pharmacodynamics principles

Park JC

Pharmacokinetics is the study of the rate and degree of drug transport to various tissues in the human body. Pharmacokinetic parameters summarize drug kinetics and ideally predict a clinical situation....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Study of First-in-Human Dose Estimation Approaches using Pharmacometrics

Baek IH

OBJECTIVE: First-in-human dose estimation is an essential approach for successful clinical trials for drug development. In this study, we systematically compared first-in-human dose and human pharmacokinetic parameter estimation approaches. METHODS: First-in-human...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetic variability due to environmental differences

Holford N

This tutorial describes sources of pharmacokinetic variability that are not obviously linked to genetic differences. The sources of variability are therefore described as environmental. The major quantitative sources of environmental...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Piroxicam Pharmacokinetics and Anti-Inflammatory Effect in Rats after Intra-Articular and Intramuscular Administration

Park CW, Ma KW, Jang SW, Son M, Kang MJ

  • KMID: 2170645
  • Biomol Ther.
  • 2014 May;22(3):260-266.
This study evaluated the pharmacokinetic profile and therapeutic efficacy of piroxicam (PX), a long acting non-steroidal anti-inflammatory drug for the treatment of arthritis, following intra-articular (IA) injection in comparison to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tacrolimus versus Cyclosporine Immunosuppression in Pediatric Renal Transplantation: Pharmacokinetic Consideration

Kim JS

  • KMID: 2278619
  • Korean J Pediatr.
  • 2005 May;48(5):476-480.
Immunosuppressive therapy in pediatric renal transplant recipients is changing consequence of the increasing number of available immunosuppressive agents. The optimal use of immunosuppressive agents requires a thorough understanding of the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetic and pharmacodynamic modeling in anesthetic field

Han DW

  • KMID: 1797465
  • Anesth Pain Med.
  • 2014 Apr;9(2):77-86.
Models are simplified descriptions of true biological processes. Pharmacokinetic/pharmacodynamic (PK/PD) modeling is a mathematical description on the relationship between pharmacokinetics and pharmacodynamics. The PK/PD modeling allows estimation of PK/PD parameters...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Population Pharmacokinetic and Pharmacodynamic Modeling in Beagle Dogs Sedated by Propofol Microemulsion

Choi BM, Jung SM, Bae KS, Noh GJ

BACKGROUND: Aquafol(R) is a microemulsion formulation of propofol. This study was designed to investigate the population pharmacokinetic and pharmacodynamic modeling in beagle dogs sedated by Aquafol(R). METHODS: Electroencephalogram was recorded...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes of Propranolol Pharmacokinetic Parameters According to Hepatic Fibrotic Severity in CCl4-Treated Rats

Kang MS, Yoon CO, Byun JW, Lee OY, Yoon BC, Hahm JS, Kang JS, Lee MH

  • KMID: 2241247
  • Korean J Hepatol.
  • 2001 Jun;7(2):181-188.
BACKGROUND/AIMS: This study was designed to determine the effect of hepatic fibrotic severity on pharmacokinetics of propranolol in CCl4-treated rats. METHODS: 1 mL/kg of 10% CCl4 in olive oil...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Understanding the pharmacokinetics of prodrug and metabolite

Cho S, Yoon YR

This tutorial explains the pharmacokinetics of a prodrug and its active metabolite (or parent drug) using a two-step, consecutive, first-order irreversible reaction as a basic model for prodrug metabolism. In...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Interspecies pharmacokinetic scaling of 11-hydroxyaclanomycin X based on animal data

Shin DH, Lee SY, Jeong SW, Park CW, Chung YB

The pharmacokinetics of 11-Hydroxyaclacinomycin X (HAMX), a novel anthracycline, were investigated after intravenous bolus administration in mice, rats, rabbits and dogs. Based on animal data, we predicted the following human...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetic Equivalence of the High Dose Strength Fixed-Dose Combination Tablet of Gemigliptin/Metformin Sustained Release (SR) and Individual Component Gemigliptin and Metformin XR Tablets in Healthy Subjects

Cho YS, Lee SH, Lim HS, Bae KS

BACKGROUND: In type 2 diabetes mellitus therapy, fixed-dose combination (FDC) can offer not only benefits in glucose control via the combined use of agents, but also increase patient compliance. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative pharmacokinetic and tolerability evaluation of two simvastatin 20 mg formulations in healthy Korean male volunteers

Moon SJ, Lee S, Jang K, Yu KS, Yim SV, Kim BH

Simvastatin is used to reduce plasma cholesterol by inhibiting 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and is primarily used to treat hypercholesterolemia. This study was conducted to assess the bioequivalence between...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Cystatin C Is a Major Predictor of Vancomycin Clearance in a Population Pharmacokinetic Analysis of Patients with Normal Serum Creatinine Concentrations

Chung JY, Jin SJ, Yoon JH, Song YG

We developed a population pharmacokinetic model of vancomycin by integrating the effects of cystatin C and other demographic factors in a large population of Korean patients with normal serum creatinine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacokinetic Interaction of Chrysin with Caffeine in Rats

Noh K, Oh DG, Nepal MR, Jeong KS, Choi Y, Kang MJ, Kang W, Jeong HG, Jeong TC

Pharmacokinetic interaction of chrysin, a flavone present in honey, propolis and herbs, with caffeine was investigated in male Sprague-Dawley rats. Because chrysin inhibited CYP1A-selective ethoxyresorufin O-deethylase and methoxyresorufin O-demethylase activities...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preclinical Pharmacokinetic Evaluation of beta-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in Rats

Kim I, Kim H, Ro J, Jo K, Karki S, Khadka P, Yun G, Lee J

beta-Lapachone has drawn increasing attention as an anti-inflammatory and anti-cancer drug. However, its oral bioavailability has not been yet assessed, which might be useful to develop efficient dosage forms possibly...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The comparison of predictive performance in bispectral index prediction during target effect-site controlled infusion of propofol using different blood effect-site equilibration rate constants in the same pharmacokinetic model

Choi BM, Bang JY, Jung KW, Lee JH, Bae HY, Noh GJ

BACKGROUND: Blood-brain equilibration rate constant (k(e0)) is derived from either pharmacokinetic and pharmacodynamic modeling (k(e0_model)) or a model-independent observed time to peak effect (k(e0_tpeak)). Performance in bispectral index (BIS) prediction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Pharmacokinetic Characteristics of Methylprednisolone in Korean Renal Transplant Recipients

Ahn JH, Kahng KW, Kang JS, Shin IC, Kang CM, Kwak JY

  • KMID: 2079036
  • Korean J Nephrol.
  • 1998 Sep;17(5):798-806.
Glucocorticoids are usually given according to a standard dosing protocol regardless of individual difference. We evaluated the pharmacokinetic characteristics of methylprednisolone and the degree of interpatient variation in stable Korean...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr